Relative Bioavailability Clinical Trial
Official title:
A Randomized, Open Label, Single Subcutaneous Dose 6x3 Crossover Study to Investigate the Relative Bioavailability Among Different Eutropin Formulations in Healthy Male Volunteers
1. Compares and evaluates the relative bioavailability of single-dose subcutaneous
administration of each of the Eutropin formulations to healthy male volunteers.
2. Ensure safety and tolerability of single, subcutaneous administration of Eutropin
formulations to healthy male volunteers.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02052349 -
Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01911741 -
A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects
|
Phase 1 | |
Completed |
NCT04814472 -
Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations
|
Phase 1 | |
Completed |
NCT03934333 -
A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)
|
Phase 1 | |
Not yet recruiting |
NCT06025344 -
A Relative Bioavailability Study With a Novel PanCytoVirâ„¢ Oral Suspension (100 mg/ml)
|
Phase 1 | |
Not yet recruiting |
NCT06025318 -
An Evaluation of the Effect of Food on the PK of a Novel PanCytoVirâ„¢ Suspension (100mg/ml), in Healthy, Adult Volunteers
|
Phase 1 | |
Completed |
NCT04686669 -
A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations
|
Phase 1 | |
Completed |
NCT03483259 -
To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers
|
Phase 1 | |
Completed |
NCT05296382 -
Bioavailability of Tebipenem (SPR994) Crushed Tablet
|
Phase 1 |